Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial
ConclusionATV was able to reduce significantly itching, breast edema, and pain in patients during radiotherapy.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Atorvastatin Calcium | Breast Cancer | Cancer | Cancer & Oncology | Dermatitis | Dermatology | Drugs & Pharmacology | Lipitor | Pain | Radiation Therapy | Skin | Statin Therapy | Statistics | Study | Toxicology | Zivast